Impact of prior oral anticoagulation therapies on post‐discharge outcomes after COVID‐19: Results from a global federated health network analysis

Background The impact of chronic oral anticoagulant (OACs) use on long‐term post‐discharge outcomes after coronavirus disease 2019 (COVID‐19) hospitalisation remains unclear. Herein, we compared clinical outcomes up to 2‐years after COVID‐19 hospitalisation between patients on vitamin K antagonists...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2024-12, Vol.54 (12), p.e14299-n/a
Hauptverfasser:	Rivera‐Caravaca, José Miguel, Frost, Freddy, Marín, Francisco, Lip, Gregory Y. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Aged, 80 and over Antagonists anticoagulant Anticoagulants Anticoagulants - therapeutic use Bleeding Cause of Death coronavirus disease 2019 Coronaviruses COVID-19 COVID-19 - complications COVID-19 - mortality direct‐acting oral anticoagulants Embolism Embolism - epidemiology Factor Xa Inhibitors - therapeutic use Female Gastrointestinal Hemorrhage - chemically induced Gastrointestinal Hemorrhage - epidemiology Health risks Hemorrhage Hospitalization Humans Impact analysis Intracranial Hemorrhages - chemically induced Intracranial Hemorrhages - epidemiology Ischemia Ischemic Attack, Transient - epidemiology Ischemic Stroke - epidemiology Male Middle Aged Mortality Mortality risk Network analysis Patient Discharge Propensity Score Risk SARS-CoV-2 Stroke thrombosis Transient ischemic attack Vitamin K Vitamin K - antagonists & inhibitors vitamin K antagonist
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!